Sep 30, 2014

ANI Pharmaceuticals Q3 2014 Earnings Report

Total Revenue
$17.4M
Previous year: $7.84M
+122.1%
EPS
$0.66
Previous year: $0.16
+312.5%
Gross Profit
$14.3M
Previous year: $5.21M
+175.1%
Cash and Equivalents
$35.1M
Previous year: $10.9M
+220.7%
Free Cash Flow
$3.75M
Previous year: -$1.67M
-325.1%
Total Assets
$108M
Previous year: $43.3M
+148.7%

ANI Pharmaceuticals

ANI Pharmaceuticals